Distinguishing inflammatory bowel disease from small cell lymphoma in cats is one of the most challenging diagnostic dilemmas in feline medicine, with significant welfare implications.
Misdiagnosis leads to inappropriate treatment and prolonged suffering. Small cell lymphoma treated as IBD may progress unnecessarily due to insufficient treatment. Cats with either condition experience significant GI discomfort and weight loss. Pursuing accurate diagnosis through adequate biopsy sampling is an important welfare decision that enables targeted treatment and better quality of life.